The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer. According to a new study in Clinical ...
Sep 12, 2011
0
0
Compared to patients who had persistently high platelet reactivity, those who achieved low platelet reactivity, according to the VerifyNow P2Y12 Test, had a reduced incidence of cardiovascular death, heart attack and stent ...
Aug 30, 2011
0
0
A randomised multicentre open-label study evaluating the efficacy and safety of prolonged antiplatelet therapy in patients with coronary disease has found that 24 months' duration of dual therapy is no better than six months ...
Aug 30, 2011
0
0
The European Society of Cardiology (ESC Working Group on Thrombosis) is calling for greater attention to be paid by health care staff to reducing bleeding in patients with acute coronary syndromes (ACS) undergoing percutaneous ...
Jun 30, 2011
0
0
When taken with higher doses of aspirin (more than 300 milligrams), the experimental antiplatelet drug ticagrelor was associated with worse outcomes than the standard drug, clopidogrel, but the opposite was true with lower ...
Jun 27, 2011
0
0
Researchers in Poland have discovered that combining omega-3 fatty acids with two blood-thinning drugs, aspirin and clopidogrel, changed the process of blood clotting, potentially helping reduce the risk of heart attacks ...
Jun 21, 2011
0
0
Results of a study, involving 98,454 patients demonstrated that at 30 days following their first heart attack, RA patients were approximately 20% less likely to be prescribed standard MI treatments, such as statins and betablockers, ...
May 27, 2011
0
0
